Interaction ID
ncRI-40647672
Interaction Molecules
hsa-miR-520d-3p -- UBE2B
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
miRanda and TargetScan with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T;motor cortex
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by TargetScan and miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000119048
Description
Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In association with the E3 enzyme BRE1 (RNF20 and/or RNF40), it plays a role in transcription regulation by catalyzing the monoubiquitination of histone H2B at 'Lys-120' to form H2BK120ub1. H2BK120ub1 gives a specific tag for epigenetic transcriptional activation, elongation by RNA polymerase II, telomeric silencing, and is also a prerequisite for H3K4me and H3K79me formation. In vitro catalyzes 'Lys-11'-, as well as 'Lys-48'- and 'Lys-63'-linked polyubiquitination. Required for postreplication repair of UV-damaged DNA. Associates to the E3 ligase RAD18 to form the UBE2B-RAD18 ubiquitin ligase complex involved in mono-ubiquitination of DNA-associated PCNA on 'Lys- 164'. May be involved in neurite outgrowth.
Pubmed ID | 24389009 | Journal | Neuron |
---|---|---|---|
Title | Transcriptome-wide discovery of microRNA binding sites in human brain. | ||
Author | Boudreau RL, Jiang P, Gilmore BL, Spengler RM, Tirabassi R, Nelson JA, Ross CA, Xing Y, Davidson BL |
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-520d-3p | acute myeloid leukemia | MNDR Database |
hsa-miR-520d-3p | adenocarcinoma | MNDR Database |
hsa-miR-520d-3p | Alzheimer's disease | MNDR Database |
hsa-miR-520d-3p | arthritis | MNDR Database |
hsa-miR-520d-3p | astrocytoma | MNDR Database |
hsa-miR-520d-3p | autism spectrum disorder | MNDR Database |
hsa-miR-520d-3p | autistic disorder | MNDR Database |
hsa-miR-520d-3p | autosomal dominant disease | MNDR Database |
hsa-miR-520d-3p | autosomal recessive disease | MNDR Database |
hsa-miR-520d-3p | azoospermia | MNDR Database |
hsa-miR-520d-3p | bone disease | MNDR Database |
hsa-miR-520d-3p | brain disease | MNDR Database |
hsa-miR-520d-3p | breast cancer | MNDR Database |
hsa-miR-520d-3p | Breast Neoplasms | MNDR Database |
hsa-miR-520d-3p | cancer | MNDR Database |
hsa-miR-520d-3p | carcinoma | MNDR Database |
hsa-miR-520d-3p | Carcinoma, Non-Small-Cell Lung | MNDR Database |
hsa-miR-520d-3p | Chronic Pain | MNDR Database |
hsa-miR-520d-3p | colon cancer | MNDR Database |
hsa-miR-520d-3p | colorectal cancer | MNDR Database |
hsa-miR-520d-3p | diabetes mellitus | MNDR Database |
hsa-miR-520d-3p | dilated cardiomyopathy | MNDR Database |
hsa-miR-520d-3p | embryonal cancer | MNDR Database |
hsa-miR-520d-3p | endometriosis | MNDR Database |
hsa-miR-520d-3p | Ependymoma | MNDR Database |
hsa-miR-520d-3p | esophageal cancer | MNDR Database |
hsa-miR-520d-3p | eye disease | MNDR Database |
hsa-miR-520d-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-520d-3p | germ cell cancer | MNDR Database |
hsa-miR-520d-3p | gout | MNDR Database |
hsa-miR-520d-3p | heart disease | MNDR Database |
hsa-miR-520d-3p | Heart Failure | MNDR Database |
hsa-miR-520d-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-520d-3p | hypersensitivity reaction type II disease | MNDR Database |
hsa-miR-520d-3p | hypertension | MNDR Database |
hsa-miR-520d-3p | intellectual disability | MNDR Database |
hsa-miR-520d-3p | kidney cancer | MNDR Database |
hsa-miR-520d-3p | kidney disease | MNDR Database |
hsa-miR-520d-3p | leukemia | MNDR Database |
hsa-miR-520d-3p | liposarcoma | MNDR Database |
hsa-miR-520d-3p | Liver Neoplasms | MNDR Database |
hsa-miR-520d-3p | lung adenocarcinoma | MNDR Database |
hsa-miR-520d-3p | lung cancer | MNDR Database |
hsa-miR-520d-3p | lung disease | MNDR Database |
hsa-miR-520d-3p | lung squamous cell carcinoma | MNDR Database |
hsa-miR-520d-3p | lymphoblastic leukemia | MNDR Database |
hsa-miR-520d-3p | lymphoma | MNDR Database |
hsa-miR-520d-3p | malignant glioma | MNDR Database |
hsa-miR-520d-3p | melanoma | MNDR Database |
hsa-miR-520d-3p | middle cerebral artery infarction | MNDR Database |
hsa-miR-520d-3p | multiple myeloma | MNDR Database |
hsa-miR-520d-3p | Multiple Sclerosis, Chronic Progressive | MNDR Database |
hsa-miR-520d-3p | Myasthenia Gravis, Autoimmune, Experimental | MNDR Database |
hsa-miR-520d-3p | myopathy | MNDR Database |
hsa-miR-520d-3p | nasopharynx carcinoma | MNDR Database |
hsa-miR-520d-3p | nephroblastoma | MNDR Database |
hsa-miR-520d-3p | neuroblastoma | MNDR Database |
hsa-miR-520d-3p | neurodegenerative disease | MNDR Database |
hsa-miR-520d-3p | oral squamous cell carcinoma | MNDR Database |
hsa-miR-520d-3p | Ovarian Neoplasms | MNDR Database |
hsa-miR-520d-3p | pancreatic adenocarcinoma | MNDR Database |
hsa-miR-520d-3p | pancreatic cancer | MNDR Database |
hsa-miR-520d-3p | periodontitis | MNDR Database |
hsa-miR-520d-3p | Peripheral Nervous System Diseases | MNDR Database |
hsa-miR-520d-3p | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-520d-3p | Prostatic Neoplasms | MNDR Database |
hsa-miR-520d-3p | pulmonary tuberculosis | MNDR Database |
hsa-miR-520d-3p | relapsing-remitting multiple sclerosis | MNDR Database |
hsa-miR-520d-3p | retinal degeneration | MNDR Database |
hsa-miR-520d-3p | schizophrenia | MNDR Database |
hsa-miR-520d-3p | skin disease | MNDR Database |
hsa-miR-520d-3p | squamous cell carcinoma | MNDR Database |
hsa-miR-520d-3p | stomach cancer | MNDR Database |
hsa-miR-520d-3p | tonsil cancer | MNDR Database |
hsa-miR-520d-3p | vascular disease | MNDR Database |